2-(2-Bromo-5-chloro-benzo[b]thiophen-3-ylmethyl)-5,6-dihydroxy-pyrimidine-4-carboxylic acid

ID: ALA562080

Chembl Id: CHEMBL562080

PubChem CID: 135915182

Max Phase: Preclinical

Molecular Formula: C14H8BrClN2O4S

Molecular Weight: 415.65

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(O)c1nc(Cc2c(Br)sc3ccc(Cl)cc23)nc(O)c1O

Standard InChI:  InChI=1S/C14H8BrClN2O4S/c15-12-7(6-3-5(16)1-2-8(6)23-12)4-9-17-10(14(21)22)11(19)13(20)18-9/h1-3,19H,4H2,(H,21,22)(H,17,18,20)

Standard InChI Key:  DHGDHAVRGLBZQJ-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA562080

    ---

Associated Targets(Human)

RNASEH1 Tchem Ribonuclease H1 (14 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

pol Human immunodeficiency virus type 1 reverse transcriptase (18245 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Human immunodeficiency virus (3636 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 415.65Molecular Weight (Monoisotopic): 413.9077AlogP: 3.81#Rotatable Bonds: 3
Polar Surface Area: 103.54Molecular Species: ZWITTERIONHBA: 6HBD: 3
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: -4.01CX Basic pKa: 15.51CX LogP: 3.19CX LogD: 1.64
Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.60Np Likeness Score: -1.03

References

1. Kirschberg TA, Balakrishnan M, Squires NH, Barnes T, Brendza KM, Chen X, Eisenberg EJ, Jin W, Kutty N, Leavitt S, Liclican A, Liu Q, Liu X, Mak J, Perry JK, Wang M, Watkins WJ, Lansdon EB..  (2009)  RNase H active site inhibitors of human immunodeficiency virus type 1 reverse transcriptase: design, biochemical activity, and structural information.,  52  (19): [PMID:19791799] [10.1021/jm900597q]

Source